Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 602526, 16 pages
http://dx.doi.org/10.1155/2014/602526
Review Article

Emerging Biomarkers and Metabolomics for Assessing Toxic Nephropathy and Acute Kidney Injury (AKI) in Neonatology

1Department of Laboratory Medicine, IRCCS San Martino-IST, University Hospital, National Institute for Cancer Research, Largo Rosanna Benzi 10, 16132 Genoa, Italy
2Department of Pediatrics and Clinical Medicine, Section of Neonatal Intensive Care Unit, Puericulture Institute and Neonatal Section, Azienda Mista and University of Cagliari, 09042 Cagliari, Italy
3Division of Pediatric Clinical Pharmacology, Children’s National Medical Center, Washington, DC 20010, USA

Received 19 February 2014; Accepted 25 March 2014; Published 11 June 2014

Academic Editor: Pasquale Ditonno

Copyright © 2014 M. Mussap et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

M. Mussap, A. Noto, V. Fanos, and J. N. Van Den Anker, “Emerging Biomarkers and Metabolomics for Assessing Toxic Nephropathy and Acute Kidney Injury (AKI) in Neonatology,” BioMed Research International, vol. 2014, Article ID 602526, 16 pages, 2014. https://doi.org/10.1155/2014/602526.